107 related articles for article (PubMed ID: 37995981)
21. Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells.
Forloni M; Gupta R; Nagarajan A; Sun LS; Dong Y; Pirazzoli V; Toki M; Wurtz A; Melnick MA; Kobayashi S; Homer RJ; Rimm DL; Gettinger SJ; Politi K; Dogra SK; Wajapeyee N
Cell Rep; 2016 Jul; 16(2):457-471. PubMed ID: 27346347
[TBL] [Abstract][Full Text] [Related]
22. TET1 suppresses colon cancer proliferation by impairing β-catenin signal pathway.
Guo H; Zhu H; Zhang J; Wan B; Shen Z
J Cell Biochem; 2019 Aug; 120(8):12559-12565. PubMed ID: 30825236
[TBL] [Abstract][Full Text] [Related]
23. Tracing TET1 expression in prostate cancer: discovery of malignant cells with a distinct oncogenic signature.
Schagdarsurengin U; Luo C; Slanina H; Sheridan D; Füssel S; Böğürcü-Seidel N; Gattenloehner S; Baretton GB; Hofbauer LC; Wagenlehner F; Dansranjav T
Clin Epigenetics; 2021 Nov; 13(1):211. PubMed ID: 34844636
[TBL] [Abstract][Full Text] [Related]
24. CagA increases DNA methylation and decreases PTEN expression in human gastric cancer.
Zhang B; Zhang X; Jin M; Hu L; Zang M; Qiu W; Wang S; Liu B; Liu S; Guo D
Mol Med Rep; 2019 Jan; 19(1):309-319. PubMed ID: 30431097
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic silencing of TET1 mediated hydroxymethylation of base excision repair pathway during lung carcinogenesis.
Chen HQ; Chen DJ; Li Y; Yuan WB; Fan J; Zhang Z; Han F; Jiang X; Chen JP; Wang DD; Cao J; Liu JY; Liu WB
Environ Pollut; 2021 Jan; 268(Pt B):115860. PubMed ID: 33120142
[TBL] [Abstract][Full Text] [Related]
26. TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy.
Ren J; Chen X; Li J; Zan Y; Wang S; Tan Y; Ding Y
Epigenetics; 2024 Dec; 19(1):2323751. PubMed ID: 38431880
[TBL] [Abstract][Full Text] [Related]
27. DNMT3B and TET1 mediated DNA methylation of LATS1 regulates BC progression via hippo signaling pathway.
Wu H; Jiao Y; Guo X; Wu Z; Lv Q
Pathol Res Pract; 2022 Dec; 240():154231. PubMed ID: 36413827
[TBL] [Abstract][Full Text] [Related]
28. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori-induced aberrant demethylation and expression of GNB4 promotes gastric carcinogenesis via the Hippo-YAP1 pathway.
Liu D; Liu Y; Zhu W; Lu Y; Zhu J; Ma X; Xing Y; Yuan M; Ning B; Wang Y; Jia Y
BMC Med; 2023 Apr; 21(1):134. PubMed ID: 37016382
[TBL] [Abstract][Full Text] [Related]
30. TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer.
Han X; Zhou Y; You Y; Lu J; Wang L; Hou H; Li J; Chen W; Zhao L; Li X
Cell Biol Int; 2017 Apr; 41(4):405-414. PubMed ID: 28150354
[TBL] [Abstract][Full Text] [Related]
31. TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target.
Chen LY; Huang RL; Chan MW; Yan PS; Huang TS; Wu RC; Suryo Rahmanto Y; Su PH; Weng YC; Chou JL; Chao TK; Wang YC; Shih IM; Lai HC
J Pathol; 2019 Jul; 248(3):363-376. PubMed ID: 30883733
[TBL] [Abstract][Full Text] [Related]
32. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH
J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825
[TBL] [Abstract][Full Text] [Related]
33. MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1.
Jin S; Chen L; Wu J; Chen M; Wang H; Hu H; Yu L; Zeng S
Int J Immunopathol Pharmacol; 2023; 37():3946320231184997. PubMed ID: 37584255
[TBL] [Abstract][Full Text] [Related]
34. Immunity drives
Collignon E; Canale A; Al Wardi C; Bizet M; Calonne E; Dedeurwaerder S; Garaud S; Naveaux C; Barham W; Wilson A; Bouchat S; Hubert P; Van Lint C; Yull F; Sotiriou C; Willard-Gallo K; Noel A; Fuks F
Sci Adv; 2018 Jun; 4(6):eaap7309. PubMed ID: 29938218
[TBL] [Abstract][Full Text] [Related]
35. Hypermethylation of TET1 promoter is a new diagnosic marker for breast cancer metastasis.
Sang Y; Cheng C; Tang XF; Zhang MF; Lv XB
Asian Pac J Cancer Prev; 2015; 16(3):1197-200. PubMed ID: 25735355
[TBL] [Abstract][Full Text] [Related]
36. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
Wu J; Li H; Shi M; Zhu Y; Ma Y; Zhong Y; Xiong C; Chen H; Peng C
J Exp Clin Cancer Res; 2019 Aug; 38(1):348. PubMed ID: 31399111
[TBL] [Abstract][Full Text] [Related]
37. Competitive binding of TET1 and DNMT3A/B cooperates the DNA methylation pattern in human embryonic stem cells.
Chao L; Yang S; Li H; Long C; Xi Q; Zuo Y
Biochim Biophys Acta Gene Regul Mech; 2022 Oct; 1865(7):194861. PubMed ID: 35998875
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.
Li L; Li C; Mao H; Du Z; Chan WY; Murray P; Luo B; Chan AT; Mok TS; Chan FK; Ambinder RF; Tao Q
Sci Rep; 2016 May; 6():26591. PubMed ID: 27225590
[TBL] [Abstract][Full Text] [Related]
39. Association of TET1 expression with colorectal cancer progression.
Tian Y; Pan F; Sun X; Gan M; Lin A; Zhang D; Zhu Y; Lai M
Scand J Gastroenterol; 2017 Mar; 52(3):312-320. PubMed ID: 27846738
[TBL] [Abstract][Full Text] [Related]
40. Effects of a single transient transfection of Ten-eleven translocation 1 catalytic domain on hepatocellular carcinoma.
Liu Y; Zhu H; Zhang Z; Tu C; Yao D; Wen B; Jiang R; Li X; Yi P; Zhan J; Hu J; Ding J; Jiang L; Zhang F
PLoS One; 2018; 13(12):e0207139. PubMed ID: 30551127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
